NASDAQ:CGEM | Income Statement | Cullinan Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$44.44M$57.25M-$57.25M-$53.7M
2026-03-31$42.12M$53.7M-$53.7M-$49.66M
2025-12-31$42.95M$55.26M-$55.26M-$50.71M
2025-09-30$41.97M$55.6M-$55.6M-$50.61M
2025-06-30$61.03M$75.8M-$75.8M-$70.06M
2025-03-31$41.46M$55M-$55M-$48.5M
2024-12-31$40.49M$55.05M-$55.05M-$47.65M
2024-09-30$35.51M$48.86M-$48.86M-$40.56M-$0.69-$0.6958,337,00058,337,000
2024-06-30$36.26M$50.03M-$50.03M-$42.03M-$0.75-$0.7555,052,00055,052,000
2024-03-31$30.65M$42.99M-$42.99M-$37.15M-$0.86-$0.8643,011,00043,011,000
2023-12-31$34.85M$45.49M-$45.49M-$39.69M-$14.12M-$23.8M-$0.54-$0.54420,000420,000
2023-09-30$33.82M$44.8M-$45.24M-$39.18M$0.00-$39.18M-$0.91-$0.9142,734,00042,734,000
2023-06-30$27.39M$37.61M-$37.61M-$32.21M$0.00-$32.21M-$0.82-$0.8239,952,00039,952,000
2023-03-31$52.1M$62.76M-$62.76M-$58.14M$0.00-$57.96M-$1.42-$1.4240,682,00040,682,000
2022-12-31$0.00$21.32M$32.61M-$32.61M-$28.95M-$1.86M-$26.78M-$0.61-$0.58198,00060,000
2022-09-30$0.00$19.68M$29.77M-$29.77M-$27.41M-$2.52M-$24.8M-$0.54-$0.5445,611,00045,611,000
2022-06-30$0.00$26.41M$37.11M$239.68M$240.14M$66.07M$174.9M$3.90$3.7744,873,00046,381,000
2022-03-31$0.00$24.54M$32.66M-$32.66M-$32.46M-$19.57M-$12.1M-$0.27-$0.2744,432,00044,432,000
2021-12-31$0.00$20.88M$34.35M-$34.35M-$34.21M$0.00-$32.51M-$0.76-$0.76-177,000-177,000
2021-09-30$0.00$12.68M$18.38M-$18.38M-$18.26M$0.00-$17.35M-$0.40-$0.4043,439,00043,439,000
2021-06-30$0.00$11.78M$16.6M-$16.6M-$16.44M$0.00-$15.64M-$0.36-$0.3643,295,00043,295,000
2021-03-31$18.94M$12.42M$17.57M$1.37M$1.42M$0.00-$70,000.0041,977,336
2020-12-31$16.63M$29.17M-$29.17M-$28.35M433,828
2020-09-30$9.91M$11.5M-$11.5M$0.00-$9.86M19,721,992
2020-06-30$12.5M$14.12M-$14.12M$0.00-$8.62M19,619,748
2020-03-31$4.17M$5.54M-$5.54M$0.00-$4.97M18,747,004

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$187.4M$241.65M-$241.65M-$219.88M$0.00-$219.88M
2024-12-31$142.9M$196.92M-$196.92M-$167.46M$117,000.00-$167.38M
2023-12-31$148.16M$190.65M-$191.09M-$169.22M-$14.12M-$153.16M-$3.69-$3.6941,550,00041,550,000
2022-12-31$0.00$91.95M$132.14M$144.65M$151.32M$42.12M$111.21M$2.46$2.3845,164,00046,640,000
2021-12-31$18.94M$57.75M$86.9M-$67.95M-$67.49M$0.00-$65.57M-$1.52-$1.5243,077,00043,077,000
2020-12-31$0.00$43.21M$60.34M-$60.34M-$51.8M19,887,307